Not applicableNo Longer AvailableNCT03414489
What this trial is testing
Expanded Access for the Treatment of Advanced Cholangiocarcinoma With ABC294640 (Yeliva ®)
Who this might be right for
CholangiocarcinomaCholangiocarcinoma Non-resectableCholangiocarcinoma, Perihilar+2 more
RedHill Biopharma Limited